At TAmiRNA we drive innovation through microRNA and RNAi technology to solve unmet clinical needs. Circulating microRNAs are novel minimal-invasive biomarkers that fulfil the requirements of valuable markers. TAmiRNA excels in the identification and development of microRNA biomarkers for diagnosis and prediction of disease and treatment response with a special focus on musculoskeletal, cardiovascular and metabolic diseases. TAmiRNA is a biotech R&D company based in Vienna, Austria.